Stevens Capital Management LP trimmed its position in Chemed Co. (NYSE:CHE) by 75.2% in the 1st quarter, Holdings Channel reports. The firm owned 2,278 shares of the company’s stock after selling 6,906 shares during the quarter. Stevens Capital Management LP’s holdings in Chemed were worth $729,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also recently made changes to their positions in the company. Bremer Trust National Association purchased a new position in Chemed during the fourth quarter valued at approximately $25,000. Executive Wealth Management LLC purchased a new position in Chemed during the fourth quarter valued at approximately $27,000. Quadrant Capital Group LLC raised its position in Chemed by 184.8% during the first quarter. Quadrant Capital Group LLC now owns 94 shares of the company’s stock valued at $26,000 after acquiring an additional 61 shares in the last quarter. Paragon Capital Management LLC purchased a new position in Chemed during the first quarter valued at approximately $40,000. Finally, Financial Gravity Companies Inc. purchased a new position in Chemed during the fourth quarter valued at approximately $45,000. Hedge funds and other institutional investors own 86.05% of the company’s stock.
A number of brokerages have recently issued reports on CHE. Zacks Investment Research lowered Chemed from a “hold” rating to a “sell” rating in a research note on Thursday, May 9th. ValuEngine lowered Chemed from a “buy” rating to a “hold” rating in a research note on Wednesday, May 1st. Oppenheimer lifted their price target on Chemed from $340.00 to $370.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 30th. Finally, Royal Bank of Canada lifted their price target on Chemed from $313.00 to $318.00 and gave the stock a “sector perform” rating in a research note on Monday, February 25th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $347.00.
Chemed (NYSE:CHE) last released its quarterly earnings data on Monday, April 29th. The company reported $2.92 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.96 by ($0.04). The company had revenue of $462.03 million for the quarter, compared to analyst estimates of $468.28 million. Chemed had a return on equity of 35.19% and a net margin of 11.37%. The business’s quarterly revenue was up 5.2% on a year-over-year basis. During the same period last year, the firm posted $2.72 EPS. As a group, analysts expect that Chemed Co. will post 12.65 earnings per share for the current year.
In other Chemed news, VP Naomi C. Dallob sold 950 shares of the business’s stock in a transaction on Wednesday, February 27th. The stock was sold at an average price of $326.33, for a total transaction of $310,013.50. Following the transaction, the vice president now owns 3,652 shares of the company’s stock, valued at $1,191,757.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Michael D. Witzeman sold 735 shares of the business’s stock in a transaction on Tuesday, March 12th. The stock was sold at an average price of $328.00, for a total value of $241,080.00. Following the transaction, the vice president now directly owns 4,000 shares in the company, valued at approximately $1,312,000. The disclosure for this sale can be found here. Insiders have sold 21,245 shares of company stock worth $6,955,533 in the last three months. 3.96% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION WARNING: This piece was published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.baseballdailydigest.com/news/2019/05/17/chemed-co-che-shares-sold-by-stevens-capital-management-lp.html.
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.
Recommended Story: What are gap-down stocks?
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.